Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) is characterized by impaired leptin action

Journal of Cellular Biochemistry

Volumn 103, Issue 4, 2008, Pages 1054-1065

  Astudillo, Pablo ^a   Ríos, Susana ^a   Pastenes, Luis ^a   Pino, Ana María ^a   Rodríguez, J Pablo ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b Universidad de Chile Macul ^*  (Chile)

Author keywords

Adipocytes; Adipogenesis; Leptin; Mesenchymal stem cells; Osteoporosis; PPAR

Indexed keywords

LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CELL DIFFERENTIATION; FEMALE; HUMANS; LEPTIN; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; PPAR GAMMA;

EID: 40349103527     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21516     Document Type: Article

References (55)

1. Ahima RS, Osei SY. 2004. Leptin signaling. Physiol Behav 81:223-241.
2. Aouanadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binétruy B, Bost F. 2006. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55:281-289.
3. Auboeuf D, Rieusset J, Fajas L, Valuer P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H. 1997. Tissue distribution and quantitation of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-a in humans: No alterations in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327.
4. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102:341-351.
5. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. 1999. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274:30059-30065.
6. Bjorbaek C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS, Myers MG, Jr. 2000. SOCS-3 mediated feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275:40649-40657.
7. Casabiell X, Pineiro V, Peino R, Lage M, Camina J, Gallego R, Vallejo LG, Dieguez C, Casanueva FF. 1998. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 83:2149-2155.
8. Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, Montanaro D, Maggiolini M, Panno ML, Ando S. 2004. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen revceptor a in MCF-7 cell. J Biol Chem 279:19908-19915.
9. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC. 2001. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology 142:4900-4909.
10. Cheng GA, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase IB. Dev Cell 2:497-503.
11. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. 1999. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Min Res 14:700-709.
12. Diradourian C, Girard J, Pégorier J.P. 2005. Phosphorylation of PPARs: From molecular characterization to physiological relevance Biochimie 87:33-38.
13. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
14. Forsen L, Meyer HE, Midthjell K, Edna TH. 1999. Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trondelag Health Survey. Diabetologia 42:920-925.
15. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. 2002. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825-836.
16. Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzell D, Baile CA. 2005. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 20:994-1001.
17. Hess R, Pino AM, Ríos S, Fernández M, Rodríguez JP. 2005. High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J Cell Biochem 94:50-57.
18. Holloway WR, Collier FMcL, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC. 2002. Leptin inhibits osteoclast generation. J Bone Min Res 17:200-209.
19. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ2. Science 274:2100-2103.
20. Imbeault P, Vidal H, Tremblay A, Vega N, Nadeau A, Després J-P, Maurieu P. 2001. Age-related differences in messenger ribonucleic acid expression of key proteins involved in adipose cell differentiation and metabolism. J Clin Endocrinol Metab 86:828-833.
21. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
22. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC. 1996. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 97:1732-1740.
23. Kallen CB, Lazar MA. 1996. Antidiabetic thiazolidinedione inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796.
24. Karsenty G. 2001. Leptin control bone formation through a hypothalamic relay. Rec Prog Horm Res 56:401-415.
25. Kersten S, Desvergne B, Wahli W. 2000. Roles of PPARs in health and disease. Nature 405:421-424.
26. Kim GS, Hong JS, Kim SW, Koh J-M, An CS, Choi J-Y, Cheng SL. 2003. Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem 278:21920-21929.
27. Laharrague P, Larrouy D, Fontanilles AM, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Penicaud L, Casteilla L. 1998. High expression of leptin by human bone marrow adipocytes. FASEB J 12:747-752.
28. Lecka-Czernik B, Gubrij I, Moerman EA, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. 1999. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma2. J Cell Biochem 74:357-371.
29. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
30. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. 2006. Glucocorticoid-induced osteoporosis: An update. Trends Endocrinol Metab 17:144-149.
31. Meunier P, Aaron J, Edouard C, Vignon G. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies Clin Orthop Relat Res 80:147-154.
32. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. 1998. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Min Res 13:371-382.
33. Patel NG, Holder JC, Smith SA, Kumar S, Eggo MC. 2003. Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation. Diabetes 52:43-50.
34. Pino AM, Rodríguez JM, Ríos S, Astudillo P, Leiva L, Seitz G, Fernández M, Rodríguez JP. 2006. Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin. J Endocrinol 191:715-725.
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
36. Raisz LG. 1997. The osteoporosis revolution. Ann Int Med 126:458-462.
37. Reginato MJ, Krakow SL, Bailey ST, Lazar MA. 1998. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferators-activated receptor gamma. J Biol Chem 273:1855-1858.
38. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA. 2001. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Min Res 16:1426-1433.
39. Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G. 1999. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem 75:414-423.
40. Rodríguez JP, Montecinos L, Ríos S, Reyes P, Martínez J. 2000. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring the adipogenic differentiation. J Cell Biochem 79:557-565.
41. Rosen CJ, Bouxsein ML. 2006. Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43.
42. Rosen ED, Spiegelman BM. 2001. PPARg: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 12:37731-37734.
43. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Fort K, Nestler EJ, Baron R. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6:985-990.
44. Takahashi Y, Okimura Y, Mizuno I, Iida K, Takahashi T, Kaji H, Abe H, Chihara K. 1997. Leptin induce mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem 272:12897-12900.
45. Tartaglia LA. 1997. The leptin receptor. J Biol Chem 272:6093-6096.
46. Thomas T, Burguera B. 2002. Is leptin the link between fat and bone mass? J Bone Min Res 17:1563-1569.
47. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. 1999. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630-1638.
48. Thomas T, Burguera B, Melton LJ III, Atkinson EJ, Riggs BL, Khosla S. 2000. Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in men and women. Metabolism 49:1278-1284.
49. Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156.
50. Unger RH. 2003. Lipid overload and overflow: Metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 14:398-403.
51. Verma S, Rajaratnam JH, Denyon J, Hoyland JA, Byers RJ. 2002. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55:693-698.
52. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM. 2001. Interferon-γ-induced regulation of peroxisome proliferators-activated receptor γ and STATs in adipocytes. J Biol Chem 276:7062-7068.
53. Wang M-y, Orci L, Ravazzola M, Unger HR. 2005. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: Implications for treatment of human obesity. Proc Natl Acad Sci USA 102:18011-18016.
54. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG. 2002. PTP-1B regulates leptin signal transduction in vivo. Dev Cell 2:489-495.
55. Zayzafon M, Gathings WE, McDonald JM. 2004. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology 145:2421-2432.